---
title: "Using Patient Claims Data to Model & Risk Stratify the U.S. Asthma Population"
description: ""
url: "https://pmsa.org/webinars/webinar-archive/item/using-patient-claims-data-to-model-risk-stratify-the-u-s-asthma-population?category_id=36"
date: "2026-06-14T21:26:02+00:00"
language: "en-GB"
---

#  Using Patient Claims Data to Model & Risk Stratify the U.S. Asthma Population

### Description

Asthma presents a large burden to the U.S. healthcare system:

- Estimated prevalence of 26 million
- Annual health expenditure of approximately $50B
- Severe flare-ups account for 1.7 million emergency department visitsannually

An unmet need for more advanced treatment persists.

In this webinar, Pfizer and Veeva will discuss how they modeled asthma exacerbation risk factors. Using longitudinal medical and pharmacy claims data, they investigated:

- The landscape of asthma in the U.S.
- COVID-19-related trends
- Which risk factors predict asthma exacerbations across all providersettings

Their findings show how patient data can be integral to identifying the right patient sub-groups for drug development and to inform better disease management strategies for patients.

Speakers:

- Andres Quintero, M.D., M.P.H., M.B.A., Global Medical Affairs Director, Glucocorticoid Portfolio Lead, Pfizer
- Patryk Skowron, Ph.D., Data Scientist, Veeva Systems - Commercial Analytics

### Sponsored by:

Pfizer and Veeva

### Back to:

[Webinars](https://pmsa.org/webinars/webinar-archive) | [Pfizer](https://pmsa.org/webinars/webinar-archive/category/pfizer) | [Veeva](https://pmsa.org/webinars/webinar-archive/category/veeva)

## Schema

```json
{
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
        {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://pmsa.org"
        },
        {
            "@type": "ListItem",
            "position": 2,
            "name": "Webinar Archive",
            "item": "https://pmsa.org/webinars/webinar-archive"
        },
        {
            "@type": "ListItem",
            "position": 3,
            "name": "Veeva",
            "item": "https://pmsa.org/webinars/webinar-archive/category/veeva"
        },
        {
            "@type": "ListItem",
            "position": 4,
            "name": "Using Patient Claims Data to Model & Risk Stratify the U.S. Asthma Population",
            "item": "https://pmsa.org/webinars/webinar-archive/item/using-patient-claims-data-to-model-risk-stratify-the-u-s-asthma-population"
        }
    ]
}
```

```json
{
    "@context": "https://schema.org",
    "@type": "Article",
    "mainEntityOfPage": {
        "@type": "WebPage",
        "@id": "https://pmsa.org/webinars/webinar-archive/item/using-patient-claims-data-to-model-risk-stratify-the-u-s-asthma-population"
    },
    "headline": "Using Patient Claims Data to Model & Risk Stratify the U.S. Asthma Population",
    "description": "Asthma presents a large burden to the U.S. healthcare system: Estimated prevalence of 26 million Annual health expenditure of approximately $50B Severe flare-ups account for 1.7 million emergency department visitsannually An unmet need for more advanced treatment persists. In this webinar, Pfizer and Veeva will discuss how they modeled asthma exacerbation risk factors. Using longitudinal medical and pharmacy claims data, they investigated: The landscape of asthma in the U.S. COVID-19-related trends Which risk factors predict asthma exacerbations across all providersettings Their findings show how patient data can be integral to identifying the right patient sub-groups for drug development and to inform better disease management strategies for patients. Speakers: Andres Quintero, M.D., M.P.H., M.B.A., Global Medical Affairs Director, Glucocorticoid Portfolio Lead, Pfizer Patryk Skowron, Ph.D., Data Scientist, Veeva Systems - Commercial Analytics",
    "image": {
        "@type": "ImageObject",
        "url": "https://pmsa.org/_resources/images/zoo/webinars/2023/01-15-23-Using.jpg"
    },
    "publisher": {
        "@type": "Organization",
        "name": "Pharmaceutical Management Science Association",
        "logo": {
            "@type": "ImageObject",
            "url": "https://pmsa.org//images/gsd.png"
        }
    },
    "author": {
        "@type": "Person",
        "name": "Paul Scarnegie",
        "url": "https://pmsa.org/webinars/webinar-archive/item/using-patient-claims-data-to-model-risk-stratify-the-u-s-asthma-population?category_id=36"
    },
    "datePublished": "2023-07-24T16:40:08+00:00",
    "dateCreated": "2023-01-15T00:00:00+00:00",
    "dateModified": "2025-10-27T13:29:49+00:00"
}
```